Catasys Inc. (CATS) Given $12.00 Consensus Target Price by Analysts
Catasys Inc. (NASDAQ:CATS) has earned a consensus broker rating score of 1.00 (Strong Buy) from the one brokers that cover the company, Zacks Investment Research reports. One analyst has rated the stock with a strong buy recommendation.
Brokerages have set a 1-year consensus target price of $12.00 for the company, according to Zacks. Zacks has also given Catasys an industry rank of 60 out of 265 based on the ratings given to its competitors.
Separately, Zacks Investment Research cut Catasys from a “hold” rating to a “sell” rating in a report on Friday, June 9th.
Hedge funds have recently bought and sold shares of the business. Bard Associates Inc. acquired a new stake in Catasys in the 2nd quarter valued at about $1,012,000. Perkins Capital Management Inc. acquired a new stake in Catasys in the 2nd quarter valued at about $113,000. FNY Partners Fund LP acquired a new stake in Catasys in the 2nd quarter valued at about $1,560,000. UBS Oconnor LLC acquired a new stake in Catasys in the 2nd quarter valued at about $834,000. Finally, Kennedy Capital Management Inc. acquired a new stake in Catasys in the 2nd quarter valued at about $1,385,000. 7.16% of the stock is currently owned by institutional investors.
Catasys (CATS) traded down 0.20% during mid-day trading on Friday, hitting $5.02. The company had a trading volume of 70,268 shares. The company has a 50-day moving average price of $4.87 and a 200 day moving average price of $6.04. Catasys has a 52-week low of $3.56 and a 52-week high of $14.00. The company’s market capitalization is $79.76 million.
Catasys (NASDAQ:CATS) last announced its earnings results on Tuesday, August 15th. The company reported ($0.23) EPS for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.03). The company had revenue of $1.67 million during the quarter. On average, analysts forecast that Catasys will post ($1.26) EPS for the current fiscal year.
Catasys, Inc provides data analytics based specialized behavioral health management and integrated treatment services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services. The companys OnTrak solution includes medical and psychosocial interventions; and a proprietary Web based clinical information platform and database, psychosocial programs, and integrated care coaching services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Catasys Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys Inc. and related companies with MarketBeat.com's FREE daily email newsletter.